Rosacea
A cutaneous disorder primarily of convexities of the central part of the FACE, such as FOREHEAD; CHEEK; NOSE; and CHIN. It is characterized by FLUSHING; ERYTHEMA; EDEMA; RHINOPHYMA; papules; and ocular symptoms. It may occur at any age but typically after age 30. There are various subtypes of rosacea: erythematotelangiectatic, papulopustular, phymatous, and ocular (National Rosacea Society's Expert Committee on the Classification and Staging of Rosacea, J Am Acad Dermatol 2002; 46:584-7).
Subtype terms (1)
More specific conditions that are subtypes of Rosacea in the MeSH hierarchy.
Drugs by status
Approved for this indication (9)
Phase 4 trials (9)
Phase 3 trials (5)
Phase 2 trials (32)
- roflumilast
- secukinumab
- amitriptyline
- b244
- bfh772
- clascoterone
- apremilast
- cromoglicic acid
- dmt210
- drm02
- idp-115
- imipramine
- bmx-010
- pac-14028
- pdi-320
- rifaximin
- dapsone
- itraconazole
- incobotulinumtoxinA
- accu-d1
- oxygen
- sodium chloride
- hypromelloses
- naphazoline
- erenumab
- aiv001
- pf-07038124
- staphylococcus epidermidis
- lotilaner
- cgb-400
- +2 more
Phase 1 trials (8)
Organizations
Organization Involved with Phase 4 Indications (12)
Organization Involved with Phase 3 Indications (66)
- Fougera
- Actavis
- DPT Laboratories
- Medicis
- Bausch Health Companies
- Perrigo
- Cutanea Life Sciences, Inc.
- Foamix Ltd.
- Laboratoires Bailleul-Biorga
- Teva
- bioRASI, LLC
- Zydus Discovery DMCC
- QuantaBio
- Sol-Gel Technologies, Ltd.
- Harvard University
- University of Michigan
- Wake Forest University
- Dermatology, Laser & Vein Specialists of the Carolinas
- Tennessee Clinical Research Center
- University of California, San Francisco
- Taro Pharmaceuticals
- Catawba Clinical Research
- Windsor Clinical Research
- Philadelphia Institute of Dermatology
- Akesis, LLC
- The Education & Research Foundation, Inc.
- Oregon Medical Research Center
- Hamzavi Dermatology
- PMG Research
- Minnesota Clinical Study Center
- +36 more
Organization Involved with Phase 2 Indications (33)
- Novelion Therapeutics
- Coria Laboratories
- Vicept Therapeutics
- PreCision Dermatology
- Celgene
- AOBiome LLC
- Novartis
- Amorepacific Corporation
- Aria Aesthetics Inc.
- Dow Pharmaceutical Sciences
- KGL, Inc.
- Merz
- Sponsor GmbH
- Therapeutics, Inc.
- Accenture
- Accuitis, Inc.
- Dermata Therapeutics
- Dermira, Inc.
- DeNova Research
- Stanford University
- Columbia University
- Dermatology Specialists Research
- University of California, San Diego
- University of Copenhagen
- BioPharmX
- Chung-Ang University
- Dr. Reddy's Laboratories
- Universitaetsklinikum Schleswig-Holstein
- BioMimetix Pharmaceutical, Inc.
- Alfasigma S.p.A.
- +3 more
Organization Involved with Phase 1 Indications (8)
Organization Involved with Other Experimental Indications (5)